Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-β1-induced expression of p15/INK4B

Molecular and Cellular Endocrinology

Volumn 176, Issue 1-2, 2001, Pages 29-37

  Frost, Simon J ^a   Simpson, David J ^a   Farrell, William E ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Cell cycle; GH3; p15Ink4b; Pituitary; TGF 1

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HYPOPHYSIS CELL; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; G1 PHASE; GENE EXPRESSION REGULATION; KINETICS; PITUITARY GLAND; PROTO-ONCOGENE PROTEINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0035947397     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(01)00477-4     Document Type: Article

References (28)

1. Albaladejo V., Fei Z.L., Nicolas B., Joly-Pharaboz M.O., Avallet O., Vigier M., Andre J. Possible involvement of transforming growth factor-beta in the inhibition of rat pituitary tumor growth by estradiol. J. Steroid. Biochem. Mol. Biol. 41:1992;125-134.
2. Alexandrow M.G., Moses H.L. Transforming growth factor β and cell cycle regulation. Cancer Res. 55:1995;1452-1457.
3. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., Issa J-P. Alteration in DNA methylation: a fundamental aspect of neoplasia. Vande Woude G.F., Kleine G. Advances in Cancer Research. 72:1998;141-196 Academic Press San Diego, CA.
4. Burns G., Sarkar D.K. Transforming growth factor beta 1-like immunoreactivity in the pituitary gland of the rat: effects of estrogen. Endocrinolgy. 133:1993;1444-1449.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Dahia P.L., Aguiar R.C.T., Honneger J., Fahlbush R., Jordan S., Lowe D.G., Lu X., Clayton R.N., Besser G.M., Grossman A.B. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumors. Oncogene. 16:1998;69-76.
7. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic. Acids Res. 11:1983;1475-1489.
8. Ewen M.E., Sluss H.K., Whitehouse L.L., Livingston D.M. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell. 74:1993;1009-1020.
9. Furth J., Clifton J.H. Experimental pituitary tumours. Harris G.W., Donovan B.T. The Pituitary Gland. 1966;460-497 Buttersworth, London.
10. INK4B is a potential effector of TGFβ-induced cell cycle arrest. Nature. 371:1994;257-261.
11. Heaney A.P., Horwitz G.A., Wang Z., Singson R., Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nature Med. 5:1999;1317-1321.
12. Kay E.P., Lee H.K., Park K.S., Lee S.C. Indirect mitogenic effect of transforming growth factor-beta on cell proliferation of subconjunctival fibroblasts. Invest. Opthalmol. Vis. Sci. 39:1998;481-486.
13. Lloyd R.V., Jin L., Qian X., Kulig E. Aberrant p27 expression in endocrine and other tumours. Am. J. Pathol. 150:1997;401-407.
14. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishidu N., Horii I., Loh D.Y., Nakayama K.-I. Mice lacking p27(Kip1) display increase body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:1996;707-720.
15. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocytes apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
16. Oka H., Jin L., Kulig E., Scheithauer B.W., Lloyd R.V. Pituitary adenylate cyclase-activating polypeptide inhibits transforming growth factor-β1-induced apoptosis in a human pituitary adenoma cell line. Am. J. Pathol. 155:1999;1893-1900.
17. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., Rolfe M. Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:1995;682-685.
18. Pastorcic M., De A., Boyadjieva N., Vale W., Sarkar D.K. Reduction in the expression and action of transforming factor β1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary. Cancer Res. 55:1995;4892-4898.
19. Pestell R.G., Albanese C., Reutens A.T., Segall J.E., Lee R.J., Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr. Rev. 20:1999;501-534.
20. Qian X., Jin L., Grande J.P., Lloyd R.V. Transforming growth factor-β and p27 expression in pituitary cells. Endocrinology. 137:1996;3051-3060.
21. Qian X., Jin L., Lloyd R.V. Expression and regulation of transforming growth factor β1 in cultured normal and neoplastic rat pituitary cells. Endocr. Pathol. 7:1996;77-90.
22. 1 in normal and neoplastic rat pituitary cells. Endocr. Pathol. 8:1997;241-250.
23. Kip1 expression in rodent pituitary cell lines. Am. J. Pathol. 153:1998;1475-1482.
24. 4 pituitary tumour cell proliferation. Endocrinology. 128:1991;1981-1990.
25. Roberts A.B., Sporn M.B. The transforming growth factor-βs. Sporn M.B., Roberts A.B. Peptide growth factors and their receptors. 1990;419-472 Springer-Verlag, Berlin.
26. Simpson D.J., Bicknell J.E., McNicol A.M., Clayton R.N., Farrell W.E. Hypermethylation of the p16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas. Genes Chrom. Cancer. 24:1999;328-336.
27. Woloschak M., Yu A., Post K.D. Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation. Mol. Carcinogen. 19:1997;221-224.
28. Zhao Y., Young S.L. Requirement of transforming growth factor-beta (TGF-beta) type II receptors for TGF-beta induced proliferation and growth inhibition. J. Biol. Chem. 271:1996;2369-2372.